A Phase 3 Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician’s Choice as Second-line Treatment for Participants with Recurrent or Metastatic Cervical Cancer (MK-2870-020)

Project: Clinical studiesClinical Study (Industry project)

Project Details

Short titleMK-2870-020
StatusActive
Effective start/end date07.11.202406.11.2029

Fields of science

  • 302024 Haematology
  • 302055 Oncology
  • 302022 Gynaecology
  • 302014 Endocrinology